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The association of clinical indication for exercise stress 
testing with all-cause mortality: the FIT Project
Joonseok Kim1,2, Mouaz Al-Mallah3,4, Stephen P. Juraschek2, Clinton Brawner3, Steve J. Keteyian3, 
Khurram Nasir2, Zeina A. Dardari2, Roger S. Blumenthal2, Michael J. Blaha2
A b s t r a c t
Introduction: We hypothesized that the indication for stress testing provid-
ed by the referring physician would be an independent predictor of all-cause 
mortality.
Material and methods: We studied 48,914 patients from The Henry Ford 
Exercise Testing Project (The FIT Project) without known congestive heart 
failure who were referred for a clinical treadmill stress test and followed for 
11 ±4.7 years. The reason for stress test referral was abstracted from the clin-
ical test order, and should be considered the primary concerning symptom or 
indication as stated by the ordering clinician. Hierarchical multivariable Cox 
proportional hazards regression was performed, after controlling for poten-
tial confounders including demographics, risk factors, and medication use as 
well as additional adjustment for exercise capacity in the final model. 
Results: A total of 67% of the patients were referred for chest pain, 12% for 
shortness of breath (SOB), 4% for palpitations, 3% for pre-operative evalua-
tion, 6% for abnormal prior testing, and 7% for risk factors only. There were 
6,211 total deaths during follow-up. Compared to chest pain, those referred 
for palpitations (HR = 0.72, 95% CI: 0.60–0.86) and risk factors only (HR = 0.72, 
95% CI: 0.63–0.82) had a lower risk of all-cause mortality, whereas those re-
ferred for SOB (HR = 1.15, 95% CI: 1.07–1.23) and pre-operative evaluation 
(HR = 2.11, 95% CI: 1.94–2.30) had an increased risk. In subgroup analysis, 
referral for palpitations was protective only in those without coronary artery 
disease (CAD) (HR = 0.75, 95% CI: 0.62–0.90), while SOB increased mortality 
risk only in those with established CAD (HR = 1.25, 95% CI: 1.10–1.44).
Conclusions: The indication for stress testing is an independent predictor 
of mortality, showing an interaction with CAD status. Importantly, SOB may 
be associated with higher mortality risk than chest pain, particularly in pa-
tients with CAD.
Key words: exercise stress test, coronary disease, coronary artery disease, 
reason for stress test, physical fitness.
Introduction
Exercise stress tests have been used for more than six decades [1] 
to detect coronary artery disease (CAD), evaluate physical capacity, and 
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predict overall prognosis [2]. Multiple modalities 
of stress tests have been proposed to increase 
sensitivity and improve risk stratification associ-
ated with functional testing. Despite this, the ex-
ercise stress test remains the preferred approach, 
as it provides an evaluation not only of coronary 
artery disease but also of exercise tolerance and 
cardiorespiratory fitness. Thus far, numerous vari-
ables including exercise capacity [3], exercise hy-
potension [4], maximal achieved heart rate [5], 
rate-pressure product [6], and heart rate recovery 
[7] have been associated with cardiovascular out-
comes and overall prognosis.
The traditional use of the exercise stress test 
to assess patients with chest pain has expanded 
to evaluate other exercise-related symptoms (“an-
gina equivalents”) when there is a  suspicion for 
CAD [8, 9]. A recent study on the national trends 
in the use of cardiac stress testing in the United 
States between 2008 and 2010 revealed that only 
28% of cardiac stress tests were ordered for the 
evaluation of chest pain, while approximately 
72% of cardiac stress tests were ordered for other 
reasons [10].
Currently, there is no large body of data that 
has evaluated the reason for exercise stress test-
ing referral by a physician as an independent pre-
dictor of mortality. This variable, upstream of the 
stress test result, may be useful for determining 
pre-test risk. Thus, we investigated the hypothesis 
that there would be a difference in risk of death 
by indication for a stress test provided by the re-
ferring clinician. 
Material and methods
We analyzed data from the Henry Ford Exercise 
Testing Project (The FIT Project), a retrospective co-
hort study of exercise testing leveraging electronic 
medical record (EMR) data, administrative data, 
and claims files [11]. The study design and details 
have been described elsewhere [11]. The study 
population included 48,914 patients who under-
went physician-referred treadmill stress testing at 
Henry Ford Health System Affiliated Subsidiaries 
in metropolitan Detroit, MI between 1991 and 
2009. Exclusion criteria included age less than 
18 years, a  history of congestive heart failure 
(CHF), or lack of a classifiable indication for stress 
testing. Clinical and demographic data were col-
lected at the time of the stress test and augment-
ed by data from the EMR and pharmacy claims 
files [11]. A specific indication for the stress test, 
including chest pain or tightness, palpitations, 
shortness of breath (SOB)/dyspnea, pre-operative 
evaluation, abnormal prior testing (e.g., electro-
cardiogram, echocardiogram or other stress test), 
or “risk factors only”, was provided by the refer-
ring physician on the test order requisition. Only 
the primary indication provided by the referring 
physician was used in instances where multiple 
indications for the stress test were provided. All 
patients underwent a routine treadmill stress test 
using the standard Bruce protocol. Exercise ca-
pacity, assessed as metabolic equivalents (METs) 
achieved, was estimated based on final achieved 
workload. Diagnosis of CAD was defined by the 
angiographic evidence of atherosclerotic plaque 
on at least one of the coronary artery branches 
or documented history of percutaneous coronary 
intervention (PCI) or coronary artery bypass graft 
(CABG). All-cause mortality was ascertained via 
linkage with the Social Security Death Master File. 
The association between test indication and 
all-cause mortality was assessed using hierarchi-
cal multivariable Cox proportional hazards regres-
sion models. Model 1 was adjusted for basic de-
mographic variables including age, sex and race. 
Model 2 was adjusted for the variables in Model 1 
and other cardiovascular risk factors including 
resting systolic blood pressure, resting diastolic 
blood pressure, history of hypertension, anti-hy-
pertensive medication use, history of hyperlip-
idemia, lipid-lowering medication use, smoking 
status, history of diabetes mellitus, and treat-
ments for lung disease. Model 3 was adjusted 
for the variables in Model 2 as well as peak METs 
achieved during the stress test [11]. Chest pain, 
the most common reason for referral, was used as 
the reference group for the analyses. A subgroup 
analysis was performed for patients with and 
without known CAD, defined as prior myocardial 
infarction or revascularization, at the time of the 
exercise test. 
Statistical analysis
All analyses were performed using STATA ver-
sion 13 (STAT Corp, College Station, TX, USA). 
A p-value < 0.05 was considered significant.
Results
In the study population of 48,914 patients, mean 
age was 54 ±13 years, with 51% males. The popula-
tion was 63% white, 30% black and 7% other races. 
The mean Framingham Risk Score was 12 ±11%, 
and the mean ACC/AHA ASCVD risk score was 13 
±14%. 9% of the patients had a  history of CAD. 
Other baseline characteristics are shown in Table I. 
Approximately 67% of the patients were re-
ferred for chest pain, 4% for palpitations, 12% 
for SOB, 3% for pre-operative evaluation, 6% for 
abnormal prior testing (EKG, echocardiogram, or 
other stress test), and 7% on the basis of risk fac-
tors only. Over a  mean follow-up duration of 11 
±4.7 years, 6,211 all-cause deaths were observed. 
Among these, 3,860 patients were referred for 
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chest pain, 124 for palpitations, 1,032 for SOB, 
653 for pre-operative evaluation, 279 for abnor-
mal prior testing and 263 for risk factors only.
The risk of mortality by indication for exercise 
test is shown in Table II. Compared to individuals 
referred for chest pain, in models adjusted for clin-
ical risk variables, individuals referred for palpita-
tions had a 28% lower adjusted risk of mortality 
and those referred for risk factors only also had 
a  28% lower adjusted risk of mortality (Table II, 
Model 2). Conversely, using chest pain as the ref-
erence group, patients with SOB had a 15% high-
er adjusted risk of all-cause mortality, and those 
referred for pre-operative evaluation had a 111% 
higher adjusted risk. There was no significant dif-
ference in the mortality risk of those referred fol-
lowing an abnormal prior test (Table II, Model 2). 
These associations remained significant after 
adjustment for exercise capacity. Patients with 
SOB had a 12% increased risk of all-cause mortal-
ity and those referred for preoperative evaluation 
had a 55% higher risk after adjustment for peak 
METs (Table II, Model 3). A sensitivity analysis was 
performed for the interim events during follow-up, 
and it did not influence the impact of indication 
on outcomes.
Table I. Demographic and clinical characteristics 
Parameter All
 (n = 48,914)
Chest pain
(n = 32,806)
Palpitations
(n = 2,146)
Shortness  
of breath
(n = 5,885)
Pre-operative 
evaluation  
(n = 1,414)
Abnormal 
prior testing
(n = 3,031)
Risk factors 
only
(3,632)
Age 53.7 ±12.6 52.6 ±12.6 50.4 ±13.0 57.1 ±12.4 62.0 ±13.1 55.8 ±12.0 54.8 ±10.7
Gender (%):
Male 51.2 48.5 38.1 59.7 56.0 56.8 62.9
Female 48.8 51.5 61.9 40.3 44.0 43.3 37.1
Race (%):
White 63.0 58.9 70.5 73.3 67.1 64.4 76.6
Black 29.8 33.5 22.8 20.4 29.0 27.8 18.1
Other 7.1 7.6 6.8 6.3 3.9 7.9 5.3
Medical history (%):
Hypertension 62.7 60.4 53.9 66.2 81.3 66.5 72.5
Diabetes 18.5 17.4 12.4 19.3 31.6 19.7 25.2
Hyperlipidemia 44.0 41.4 37.0 48.9 38.1 48.1 62.3
Smoker 42.0 41.9 36.1 42.1 48.7 40.2 45.4
Obesity 22.9 22.2 19.7 22.1 16.7 28.7 30.2
Family history of 
CHD
51.8 52.3 51.0 48.2 42.9 47.3 61.3
CVD risk categories (%):
< 5% 39.6 43.2 56.2 29.4 18.1 33.2 28.4
5–7.5% 11.0 11.3 9.6 10.7 6.6 11.1 11.5
≥ 7.5% 49.3 45.5 34.1 59.9 75.3 55.8 60.1
Mean CVD risk 
score
13 ±14 11 ±13 9 ±12 16 ±15 23 ±19 14 ±14 14 ±14
Framingham risk categories (%):
< 10% 57.0 60.4 71.1 47.5 39.9 51.1 42.9
10–20% 26.5 25.5 18.9 29.8 26.2 28.4 33.5
≥ 20% 16.6 14.1 10.0 22.7 33.9 20.5 23.6
Mean FRS 12 ±11 11 ±10 9 ±10 14 ±12 18 ±16 13 ±11 15 ±12
Medication (%):
Hypertension 
medications
44.5 42.1 36.5 47.9 65.3 47.8 54.0
Hyperlipidemia 
medications
21.0 19.0 15.4 22.2 24.0 25.3 35.6
Lung disease 
medications
8.9 8.7 7.2 12.0 9.1 7.9 7.3
FRS – Framingham risk score.
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In a  subgroup analysis, the lower risk of all-
cause mortality for those with palpitations was 
found only in those free of known CAD (HR = 0.75, 
95% CI: 0.62–0.90) (Table III). Patients with known 
CAD who were referred for SOB had 25% in-
creased risk of all-cause mortality (HR = 1.25, 95% 
CI: 1.10–1.44), whereas patients without history 
of CAD did not have increased risk of mortality 
(HR = 1.08, 95% CI: 1.00–1.18) (Tables III and IV).
Discussion
In this large, single-center, retrospective cohort 
study, we observed that patients referred for an 
exercise stress test as part of a pre-operative eval-
uation or for assessment of SOB had the greatest 
risk of mortality, those with chest pain had inter-
mediate risk, while those referred for palpitations 
or risk factors only had the lowest risk. These ro-
bust associations remain significant after compre-
hensive adjustment for pertinent clinical variables 
including exercise capacity. Interestingly, this ef-
fect was modified by clinical CAD status. To our 
knowledge, this is the first study to suggest that 
indications for stress testing, including chest pain 
and dyspnea, provided by the treating physicians 
are independent predictors of overall mortality. 
There have been a  few prior efforts to inves-
tigate the prognostic significance of presenting 
symptoms focused on SOB and chest pain. Abidov 
et al. studied 17,991 patients without known val-
vular disease or cardiomyopathy who underwent 
myocardial perfusion stress testing [12]. Patients 
were divided into groups according to presenting 
symptoms including chest pain and dyspnea. Af-
ter a  follow-up of 2.7 years, it was demonstrated 
that patients who have dyspnea but are otherwise 
asymptomatic are at increased risk of cardiac and 
Table II. Association of indication of stress test and all-cause mortality
Indication for  
stress test
Model 1 Model 2 Model 3
Hazard 
ratio
95% CI P-value Hazard 
ratio
95% CI P-value Hazard 
ratio
95% CI P-value
Chest pain  
(n = 32,806)
1.00 1.00 1.00
Palpitations  
(n = 2,146)
0.70 0.59–0.84 < 0.001 0.72 0.60–0.86 < 0.001 0.79 0.66–0.95 0.012
Shortness of breath 
(n = 5,885)
1.11 1.05–1.20 0.001 1.15 1.07–1.23 < 0.001 1.12 1.05–1.20 0.001
Pre-operative 
evaluation (n = 1,414)
2.47 2.27–2.68 < 0.001 2.11 1.94–2.30 < 0.001 1.55 1.42–1.70 < 0.001
Abnormal prior 
testing (n = 3,031)
0.97 0.86–1.10 0.657 0.99 0.87–1.11 0.814 0.98 0.86–1.10 0.706
Risk factors only  
(n = 3,632)
0.72 0.64–0.82 < 0.001 0.72 0.63–0.82 < 0.001 0.76 0.67–0.86 < 0.001
Model 1 – Adjusted for age, sex, race. Model 2 – Adjusted for variables in Model 1 plus resting systolic blood pressure, resting diastolic 
blood pressure, history of hypertension, anti-hypertensive medication use, history of hyperlipidemia, lipid-lowering medication use, 
smoking status, history of diabetes mellitus, and treatments for lung disease. Model 3 – Adjusted for variables in Model 2 plus peak METs.
Table III. Association of indication of stress test and all-cause mortality in patients without history of CAD
Indication for  
stress test
Model 1 Model 2 Model 3
Hazard 
ratio
95% CI P-value Hazard 
ratio
95% CI P-value Hazard 
ratio
95% CI P-value
Chest pain  
(n = 30,051)
1.00 1.00 1.00
Palpitations  
(n = 2,092)
0.73 0.61–0.89 0.001 0.75 0.62–0.90 0.003 0.83 0.68–1.00 0.053
Shortness of breath 
(n = 5,208)
1.06 0.98–1.15 0.175 1.08 1.00–1.18 0.059 1.10 1.01–1.20 0.022
Pre-operative 
evaluation (n = 1,139)
2.47 2.27–2.68 < 0.001 2.16 1.96–2.39 < 0.001 1.60 1.44–1.77 < 0.001
Abnormal prior 
testing (n = 2,886)
1.01 0.89–1.15 0.859 1.01 0.89–1.16 0.829 1.01 0.88–1.15 0.897
Risk factors only  
(n = 3,457)
0.79 0.69–0.90 < 0.001 0.79 0.69–0.90 < 0.001 0.82 0.72–0.94 0.462
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all-cause mortality compared to asymptomatic pa-
tients and patients with typical angina. This result 
is in line with the recent meta-analysis on the prog-
nostic significance of dyspnea and chest pain. Ar-
gulian et al. reported that patients who had a stress 
test due to dyspnea had higher all-cause mortality 
compared to those who had a  stress test due to 
chest pain (annual mortality 4.9% vs. 2.3%, OR = 
2.57, p < 0.001) [13]. Unfortunately, these studies 
are limited by a lack of other indications for stress 
testing that we have evaluated in this study. 
Given that an increased risk of mortality for 
those referred for SOB was observed only in those 
with known CAD, it is possible that SOB may be 
a  more sensitive manifestation of ischemia or 
undiagnosed cardiomyopathy in this population. 
For example, it is well established that SOB could 
represent more severe cardiac ischemia as an an-
gina equivalent [14]. Our data suggest that SOB 
may represent a more advanced form of chronic 
disease in patients with CAD than that represent-
ed by chest pain. Chase et al. found that patients 
who had to terminate a stress test due to SOB had 
a higher New York Heart Association class, lower 
peak oxygen consumption and a  higher minute 
ventilation/carbon dioxide production slope com-
pared to those who stopped due to chest pain af-
ter adjustment for resting ejection fraction [15].
Despite face validity from a  clinical point of 
view, it is not immediately apparent why patients 
with palpitations had a  lower risk of mortality 
compared to those with chest pain. This could be 
explained by the fact that palpitations in isolation 
are generally not considered a major risk factor of 
ischemic heart disease in the absence of high-risk 
features [16]. Weber and Kapoor demonstrated 
that the short-term prognosis of healthy patients 
with palpitations is excellent. Furthermore, only 
43% of palpitations were of cardiac origin, and the 
etiology of the rest were noncardiac including psy-
chiatric reasons [16]. Unfortunately, our registry 
did not capture the details of palpitation includ-
ing duration and types; therefore we are unable to 
further ascertain the mechanism of this associa-
tion. Our result emphasizes that palpitations may 
not always warrant further cardiac evaluation 
with exercise stress testing as all-cause mortality 
is lower than that of other indications of exercise 
stress testing.
Preoperative patients chosen for stress testing 
are likely to represent a sicker subset of the gener-
al population of patients with planned surgery. Our 
analysis suggests that this higher risk of death ex-
tends beyond risk factor and exercise capacity ad-
justment, perhaps reflecting the overall physician 
sense of a  sicker patient. We repeated the anal-
yses after excluding deaths during the first year 
of follow-up to minimize possible confounding by 
surgery itself (if surgery was indeed ultimately per-
formed), and the overall results were unchanged. 
Nevertheless, it cannot be ruled out that pre-op-
erative patients were high-risk patients who had 
a more significant disease burden including heart 
disease than the general population, which would 
affect the overall mortality. Therefore, this result 
should be interpreted with caution and should not 
be generalized prematurely.
Strengths of this study include its large, diverse 
cohort without history of CHF at baseline, and hav-
ing various reasons for stress testing provided by 
the ordering physician. A recent analysis from the 
National Ambulatory Medical Care Survey (NAMCS) 
and the National Hospital Ambulatory Medical 
Care Survey (NHAMCS) found that more than one 
third of the stress tests ordered or performed be-
tween 2008 and 2010 were by the primary care 
physician [10]. Our study reflects the trend and ac-
tual practice in the United States that a significant 
portion of stress tests are done by referral from 
a physician other than a cardiologist [10].
Table IV. Association of indication of stress test and all-cause mortality in patients with history of CAD
Indication for  
stress test
Model 1 Model 2 Model 3
Hazard 
ratio
95% CI P-value Hazard 
ratio
95% CI P-value Hazard 
ratio
95% CI P-value
Chest pain  
(n = 2,755)
1.00 1.00 1.00
Palpitations (n = 54) 0.82 0.47–1.41 0.470 0.77 0.44–1.33 0.350 0.78 0.44–1.37 0.382
Shortness of breath 
(n = 677)
1.29 1.13–1.47 < 0.001 1.25 1.10–1.44 0.001 1.12 0.98–1.28 0.102
Pre-operative 
evaluation (n = 275)
1.99 1.69–2.34 < 0.001 1.80 1.52–2.14 < 0.001 1.38 1.16–1.65 < 0.001
Abnormal EKG or 
other stress test  
(n = 145)
1.05 0.76–1.45 0.763 1.04 0.75–1.44 0.807 0.99 0.72–1.37 0.948
Risk factors only  
(n = 175)
0.55 0.38–0.81 0.002 0.56 0.38–0.82 0.03 0.59 0.40–0.86 0.07
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There is a  national call to decrease the inap-
propriate use of cardiac stress testing. Ladapo et 
al. discovered that the frequency of cardiac stress 
testing in the US has doubled in the last 20 years, 
and at least a  third of cardiac stress tests with 
imaging were inappropriately ordered [10]. It is 
noteworthy that the outcome of patients referred 
for previous abnormal stress testing did not differ 
from that of patients with chest pain, which sug-
gests that there is no additive prognostic value of 
repeating a stress test in this population. However, 
this is likely a  select group of patients in whom 
prior abnormal results were doubted or in whom 
more invasive tests such as cardiac catheteriza-
tion were not considered indicated. Our study also 
demonstrates that patients referred for less con-
cerning indications, such as a  risk factor only or 
palpitations, are at lower risk, perhaps confirming 
that these patients may not always warrant exer-
cise stress testing. 
Our study has a number of limitations. First, our 
analysis of pre-operative referrals did not include 
potential confounding variables such as type of 
surgery, risk of surgery itself, and other comorbid-
ities including peripheral artery disease, chronic 
kidney disease and malignancy. Results for the 
pre-operative indication should be considered 
with caution. Secondly, the result of the stress 
EKG could not be factored into our analysis, as 
these data were not systematically available in the 
dataset, and we were specifically focusing on vari-
ables upstream of the stress test result to eval-
uate the clinical situation (pre-test probability or 
pre-test risk) before knowing the result. Therefore 
these data are most clinically useful to those clini-
cians who are ordering or conducting stress tests 
to help determine pre-test probability or pre-test 
risk. The types of chest pain (atypical vs. typical) 
were also systematically specified, which could 
potentially add granularity to our conclusions 
about chest pain referrals and affect the likelihood 
of a positive stress test result. Another limitation 
is that some patients may have multiple indica-
tions when referred for a stress test, but only the 
primary indication provided by the treating physi-
cian was available for this analysis.
In conclusion, our analysis showed that the in-
dication for stress testing is an independent pre-
dictor of mortality, showing an interaction with 
CAD status. When available, this variable should 
be factored into all future analyses of the prognos-
tic impact of exercise stress data. Further research 
is warranted to investigate the pathophysiology 
of these observed associations and their clinical 
implications. For example, SOB, particularly in the 
setting of established CAD, may be considered 
a  higher risk condition compared to chest pain. 
All clinicians, as well as physicians interpreting 
tests in stress labs, should carefully consider the 
primary indication for stress testing that is rou-
tinely provided by care providers most intimately 
familiar with the referred patients.
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